Hydroxychloroquine(HCQ) reduces the risk of coronary artery disease in patients with rheumatoid arthritis(RA) Chun Li Department of Rheumatology and Immunology Center

First Page		Document Content
Date: 2014-04-22 21:42:29 Rheumatoid arthritis Disease-modifying antirheumatic drug Hebei Coronary artery disease Medicine Health Anatomy Arthritis		Hydroxychloroquine(HCQ) reduces the risk of coronary artery disease in patients with rheumatoid arthritis(RA) Chun Li Department of Rheumatology and Immunology Center Add to Reading List Source URL: aplarcongress.org Download Document from Source Website File Size: 1,88 MB Share Document on Facebook

	Provincial Drug Programs P. O. Box 2000 Charlottetown PE C1A 7N8Toll Free on PEI) Programmes provinciaux de médicaments DocID: 1qAvE - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1qius - View Document
	THE EFFECTIVENESS OF NON BIOLOGIC DMARDS AFTER ANTI TNF α INHIBITOR FAILURE DECISION SUPPORT UNIT Allan Wailoo, Jonathan Tosh School of Health and Related Research, University of Sheffield DocID: 1pY4l - View Document
	TABLE OF CONTENTS INTRODUCTION 2 DocID: 1pESm - View Document
	TOCILIZUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS DocID: 1pnYX - View Document